NCT01055223
Fracture Risk With Thiazolidinediones
See it on ClinicalTrials.gov ↗98,483 people
38.3%
61.7%
37,738 womenmiddle line = equal numbers60,745 men
- Phase
- —
- Paid for by
- GlaxoSmithKline
- Finished
- 2010-03
- Health conditions
- Fractures, Bone, Type II Diabetes
- Who could join
- Anyone
- Ages
- 18 Years – 65 Years
- Average age
- mean 52.2 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No cancer
Women with current or past cancer were turned away.
“A history of fracture, osteoporosis or cancer prior to the first prescription of TZD (study begin date)”
Study titles and rules are shown in their original English.